Takeda Pharmaceutical Company Limited (TAK)
NYSE: TAK · Real-Time Price · USD
13.10
+0.09 (0.69%)
Dec 20, 2024, 4:00 PM EST - Market closed
Takeda Pharmaceutical Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Net Income | 289,996 | 144,067 | 317,017 | 230,059 | 376,005 | 44,241 | Upgrade
|
| Depreciation & Amortization | 725,890 | 695,415 | 638,839 | 583,151 | 559,671 | 583,649 | Upgrade
|
| Other Amortization | 32,587 | 32,587 | 25,561 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -5,709 | -1,780 | -6,797 | -7,174 | -232,102 | -17,346 | Upgrade
|
| Asset Writedown & Restructuring Costs | 59,379 | 150,017 | 64,394 | 54,515 | 25,452 | 101,882 | Upgrade
|
| Loss (Gain) From Sale of Investments | 23,079 | 20,757 | 3,991 | -11,195 | 59,277 | -18,387 | Upgrade
|
| Loss (Gain) on Equity Investments | -3,619 | -6,473 | 8,630 | 15,367 | -76 | 23,987 | Upgrade
|
| Stock-Based Compensation | 73,834 | 70,871 | 60,672 | 43,374 | 37,663 | 29,122 | Upgrade
|
| Other Operating Activities | -61,481 | -133,114 | -109,887 | 116,403 | -90,740 | -194,588 | Upgrade
|
| Change in Accounts Receivable | 30,406 | 15,104 | 75,127 | 127,294 | -9,316 | -34,826 | Upgrade
|
| Change in Inventory | -89,023 | -115,743 | -79,155 | -46,148 | 25,978 | 137,492 | Upgrade
|
| Change in Accounts Payable | 2,705 | -9,895 | -84,804 | 125,157 | 36,620 | -29,932 | Upgrade
|
| Change in Other Net Operating Assets | -201,738 | -145,469 | 63,568 | -107,698 | 222,499 | 44,458 | Upgrade
|
| Operating Cash Flow | 876,306 | 716,344 | 977,156 | 1,123,105 | 1,010,931 | 669,752 | Upgrade
|
| Operating Cash Flow Growth | -9.02% | -26.69% | -13.00% | 11.10% | 50.94% | 103.89% | Upgrade
|
| Capital Expenditures | -198,530 | -175,420 | -140,657 | -123,252 | -111,206 | -127,082 | Upgrade
|
| Sale of Property, Plant & Equipment | 307 | 8,606 | 962 | 1,815 | 46,453 | 12,578 | Upgrade
|
| Cash Acquisitions | - | - | - | -49,672 | - | -4,890 | Upgrade
|
| Divestitures | 27,924 | 19,959 | 7,958 | 28,196 | 530,388 | 461,546 | Upgrade
|
| Sale (Purchase) of Intangibles | -141,386 | -305,310 | -493,032 | -62,785 | -125,262 | -90,628 | Upgrade
|
| Investment in Securities | -1,731 | 1,255 | 12,103 | 8,580 | 62,008 | 41,851 | Upgrade
|
| Other Investing Activities | -55,161 | -12,952 | 5,564 | -1,007 | -8,851 | -1,256 | Upgrade
|
| Investing Cash Flow | -368,577 | -463,862 | -607,102 | -198,125 | 393,530 | 292,119 | Upgrade
|
| Short-Term Debt Issued | - | 277,000 | 40,000 | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | 100,000 | 75,000 | 249,334 | 1,179,515 | 496,190 | Upgrade
|
| Total Debt Issued | 1,151,460 | 377,000 | 115,000 | 249,334 | 1,179,515 | 496,190 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -2 | -149,043 | -351,223 | Upgrade
|
| Long-Term Debt Repaid | - | -375,487 | -400,071 | -849,809 | -1,690,976 | -731,057 | Upgrade
|
| Total Debt Repaid | -732,177 | -375,487 | -400,071 | -849,811 | -1,840,019 | -1,082,280 | Upgrade
|
| Net Debt Issued (Repaid) | 419,283 | 1,513 | -285,071 | -600,477 | -660,504 | -586,090 | Upgrade
|
| Repurchase of Common Stock | -1,882 | -2,326 | -26,929 | -77,531 | -2,141 | -3,737 | Upgrade
|
| Common Dividends Paid | -294,686 | -287,188 | -279,416 | -283,665 | -283,357 | -282,582 | Upgrade
|
| Dividends Paid | -294,686 | -287,188 | -279,416 | -283,665 | -283,357 | -282,582 | Upgrade
|
| Other Financing Activities | -72,362 | -66,415 | -117,732 | -108,592 | -142,352 | -132,804 | Upgrade
|
| Financing Cash Flow | 50,353 | -354,416 | -709,148 | -1,070,265 | -1,088,354 | -1,005,213 | Upgrade
|
| Foreign Exchange Rate Adjustments | -17,119 | 26,204 | 22,929 | 28,758 | 12,501 | -21,766 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | - | - | 629 | Upgrade
|
| Net Cash Flow | 540,963 | -75,730 | -316,165 | -116,527 | 328,608 | -64,479 | Upgrade
|
| Free Cash Flow | 677,776 | 540,924 | 836,499 | 999,853 | 899,725 | 542,670 | Upgrade
|
| Free Cash Flow Growth | -16.34% | -35.33% | -16.34% | 11.13% | 65.80% | 116.37% | Upgrade
|
| Free Cash Flow Margin | 14.91% | 12.69% | 20.77% | 28.01% | 28.14% | 16.49% | Upgrade
|
| Free Cash Flow Per Share | 425.38 | 342.28 | 532.85 | 633.95 | 571.79 | 346.49 | Upgrade
|
| Cash Interest Paid | 92,962 | 100,375 | 108,555 | 108,207 | 107,350 | 127,211 | Upgrade
|
| Cash Income Tax Paid | 167,919 | 202,039 | 185,966 | 140,423 | 201,687 | 226,768 | Upgrade
|
| Levered Free Cash Flow | 446,475 | 115,508 | 480,297 | 929,111 | 783,893 | 929,414 | Upgrade
|
| Unlevered Free Cash Flow | 520,927 | 187,628 | 553,405 | 1,005,631 | 865,646 | 1,022,545 | Upgrade
|
| Change in Net Working Capital | 380,623 | 439,427 | -74,378 | -189,748 | -237,986 | -441,165 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.